Sign in

CIK 0001799191 · Accelerated filer<br>Smaller reporting company

Starling Oncology, Inc.

Sign in to watch
Tickers
STLN DFPH
Exchange
Nasdaq, OTC
Industry
Services-Offices & Clinics of Doctors of Medicine
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
843562323
Phone
562-735-3226
Business address
18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
Former names
Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.

Securities

  • STLN Common Stock Nasdaq
  • STLNW Warrant Nasdaq
  • DFPH Common stock OTC
  1. S-3 Offering Registration Statement
  2. 8-K Event Shareholder vote results
  3. 8-K Event Executive or director change
  4. 4/A Open-market buy Director bought 45,280 shares at $1.04 ($47,168)
  5. SCHEDULE 13D/A Stake Beneficial Ownership Report
  6. 8-K Event Other events
  7. D Other Notice of Sales of Unregistered Securities
  8. 4 Grant or award Chief Medical Officer acquired 157,088 shares (grant or award)
  9. 4 Grant or award Chief Financial Officer acquired 197,368 shares (grant or award)
  10. 4 Grant or award Chief Operating Officer acquired 162,281 shares (grant or award)
  11. 4 Grant or award Chief Executive Officer acquired 1,083,334 shares (grant or award)
  12. SCHEDULE 13D/A Stake Beneficial Ownership Report
  13. 4 Grant or award Director acquired 2,716,898 shares (grant or award)
  14. 4 Open-market buy Chief Executive Officer bought 22,640 shares at $1.04 ($23,584)
  15. 4 Open-market buy Chief Medical Officer bought 9,056 shares at $1.04 ($9,434)
  16. 4 Open-market buy Director bought 90,562 shares at $1.04 ($94,338)
  17. 4 Open-market buy Director bought 36,224 shares at $1.04 ($37,735)
  18. 4 Open-market buy Director bought 9,056 shares at $1.04 ($9,434)
  19. 4 Open-market buy Chief Operating Officer bought 9,056 shares at $1.04 ($9,434)
  20. 4 Open-market buy Chief Financial Officer bought 9,056 shares at $1.04 ($9,434)

Page 8 of 28 · 549 filings